Filing Details

Accession Number:
0001209191-21-066813
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-24 16:55:23
Reporting Period:
2021-11-22
Accepted Time:
2021-11-24 16:55:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1468748 Kodiak Sciences Inc. KOD Biological Products, (No Disgnostic Substances) (2836) 270476525
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754049 Jason Ehrlich 1200 Page Mill Road
Palo Alto CA 94304
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-22 6,950 $10.29 58,491 No 4 M Direct
Common Stock Disposition 2021-11-22 191 $96.82 58,300 No 4 S Direct
Common Stock Disposition 2021-11-22 3,701 $98.63 54,599 No 4 S Direct
Common Stock Disposition 2021-11-22 1,881 $99.57 52,718 No 4 S Direct
Common Stock Disposition 2021-11-22 1,071 $100.44 51,647 No 4 S Direct
Common Stock Disposition 2021-11-22 106 $101.21 51,541 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-11-22 6,950 $0.00 6,950 $10.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
232,438 2028-08-29 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $98.06 to $99.04, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
  3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $99.12 to $100.08, inclusive.
  4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $100.155 to $101.095, inclusive.
  5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $101.17 to $101.27, inclusive.
  6. Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.